🇺🇸 FDA
Pipeline program

Saline, 0.9% Sodium Chloride Solution for Injection, JNJ-80202135, JNJ-80202135

80202135FNAIT3001

Phase 3 small_molecule active

Quick answer

Saline, 0.9% Sodium Chloride Solution for Injection, JNJ-80202135, JNJ-80202135 for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials